Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. (Record no. 25087006)

MARC details
000 -LEADER
fixed length control field 01996 a2200589 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517042816.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201604s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2047-9980
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1161/JAHA.115.001921
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name An, JaeJin
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160420
245 00 - TITLE STATEMENT
Title Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of the American Heart Association
Date of publication, distribution, etc. Jul 2015
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspirin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Atrial Fibrillation
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Coagulation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element California
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Comorbidity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Monitoring
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fibrinolytic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Health Maintenance Organizations
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemorrhage
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element International Normalized Ratio
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Longitudinal Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stroke
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Warfarin
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Niu, Fang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lang, Daniel T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jazdzewski, Kristin P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Le, Paul T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rashid, Nazia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meissner, Brian
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mendes, Robert
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dills, Diana G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aranda, Gustavus
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bruno, Amanda
773 0# - HOST ITEM ENTRY
Title Journal of the American Heart Association
Related parts vol. 4
-- no. 7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1161/JAHA.115.001921">https://doi.org/10.1161/JAHA.115.001921</a>
Public note Available from publisher's website

No items available.